🔗 Visit the ClinicalTrials.gov page for NCT02284971
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Principles of antibody-mediated TNF receptor activation. | Cell Death Differ | 2015 | 0.84 |
| 2 | Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. | Immunotherapy | 2015 | 0.81 |
| 3 | Trial Watch: Immunotherapy plus radiation therapy for oncological indications. | Oncoimmunology | 2016 | 0.81 |